Home » Authors » Nuala Moran

Articles by Nuala Moran

Acambis Moving R&D Core To U.S.,Cutting Work Force By 40

Feb. 4, 2004

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Jan. 28, 2004

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Jan. 28, 2004

Genzyme Selects Cambridge For Location Of R&D Center

Jan. 21, 2004

Genzyme Selects Cambridge For Location Of R&D Center

Jan. 21, 2004

Alizyme Performs Well In First U.S. Trial Of Renzapride In IBS

Jan. 14, 2004

De Novo Sells License To Lilly For Drug Discovery Software

Jan. 14, 2004

Alizyme Performs Well In First U.S. Trial Of Renzapride In IBS

Jan. 14, 2004

De Novo Sells License To Lilly For Drug Discovery Software

Jan. 14, 2004

Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

Jan. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.